Why the first 90 days matter most
The early weeks of GLP-1 treatment are when support makes the biggest difference
The first 90 days of GLP-1 therapy are a critical adjustment period. This is when patients are learning how their body responds, managing side effects, and translating clinical guidance into daily habits around food, hydration, and activity.
This is also when drop-off risk is highest. Without timely support, uncertainty and side effects often lead to disengagement, even among motivated patients.
Koa was designed to support patients through this window, providing real-time, voice-based guidance between visits to help patients stay engaged, supported, and aligned with their treatment plan when it matters most.
Designed to support early GLP-1 persistence, without increasing clinical workload
.png)
NuVee 2026
Tools that help patients take control of their health
Tools that help patients take control of their health
NuVee builds digital health tools designed to support patients alongside their clinical care.
NuVee does not provide medical advice or replace licensed healthcare professionals.
NuVee does not provide medical advice or replace licensed healthcare professionals.